Shares of Ambev S.A. (NYSE:ABEV) have been assigned a consensus recommendation of “Hold” from the seven research firms that are covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $6.27.
A number of analysts have issued reports on ABEV shares. Zacks Investment Research raised Ambev from a “hold” rating to a “buy” rating and set a $6.00 target price on the stock in a research report on Monday, July 10th. Barclays PLC reaffirmed a “hold” rating on shares of Ambev in a research report on Sunday, July 30th.
ILLEGAL ACTIVITY WARNING: This story was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.com-unik.info/2017/08/19/analysts-set-ambev-s-a-nyseabev-price-target-at-6-16-updated-updated-updated.html.
Several hedge funds have recently bought and sold shares of the company. Two Sigma Investments LP raised its stake in Ambev by 631.0% in the fourth quarter. Two Sigma Investments LP now owns 166,634 shares of the company’s stock worth $818,000 after buying an additional 143,839 shares in the last quarter. Quadrature Capital Ltd bought a new stake in Ambev during the fourth quarter worth $8,274,000. Migdal Insurance & Financial Holdings Ltd. bought a new stake in Ambev during the fourth quarter worth $215,000. RMB Capital Management LLC acquired a new position in Ambev during the fourth quarter valued at approximately $108,000. Finally, Macquarie Group Ltd. raised its position in Ambev by 2.9% in the fourth quarter. Macquarie Group Ltd. now owns 236,500 shares of the company’s stock valued at $1,161,000 after buying an additional 6,600 shares during the period. 7.73% of the stock is currently owned by institutional investors and hedge funds.
Ambev (ABEV) traded up 1.405% on Friday, reaching $6.135. The company’s stock had a trading volume of 7,974,961 shares. The firm has a market capitalization of $96.36 billion, a price-to-earnings ratio of 25.247 and a beta of 0.66. Ambev has a 52 week low of $4.70 and a 52 week high of $6.39. The company has a 50 day moving average of $5.81 and a 200 day moving average of $5.69.
Ambev (NYSE:ABEV) last announced its earnings results on Thursday, July 27th. The company reported $0.04 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.04. The company had revenue of $3.20 billion for the quarter, compared to analyst estimates of $3.33 billion. Ambev had a return on equity of 23.24% and a net margin of 27.14%. On average, analysts forecast that Ambev will post $0.23 earnings per share for the current year.
The business also recently disclosed a special dividend, which was paid on Monday, July 24th. Stockholders of record on Wednesday, June 28th were given a dividend of $0.0493 per share. The ex-dividend date was Monday, June 26th. This is a positive change from Ambev’s previous special dividend of $0.03. Ambev’s dividend payout ratio is currently 50.00%.
Ambev Company Profile
Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company’s activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in Dominican Republic, Saint Vincent, Antigua, Dominica, Guatemala, El Salvador, Nicaragua and Cuba; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile, Ecuador, Peru and Colombia, and Canada, represented by Labatt’s operations, which comprises sales in Canada.
What are top analysts saying about Ambev S.A.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Ambev S.A. and related companies.